Gene Expression-Based Chemical Genomics Identifies Potential Therapeutic Drugs in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is an aggressive tumor with a poor prognosis. Currently, only sorafenib is approved by the FDA for advanced HCC treatment; therefore, there is an urgent need to discover candidate therapeutic drugs for HCC. We hypothesized that if a drug signature could reverse, at lea...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Chen, Ming-Huang, Yang, Wu-Lung R., Lin, Kuan-Ting, Liu, Chia-Hung, Liu, Yu-Wen, Huang, Kai-Wen, Chang, Peter Mu-Hsin, Lai, Jin-Mei, Hsu, Chun-Nan, Chao, Kun-Mao, Kao, Cheng-Yan, Huang, Chi-Ying F.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2011
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3210146/
https://ncbi.nlm.nih.gov/pubmed/22087264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0027186
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items